This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase 2 Study to Assess Activity and Safety of F...
Clinical trial

A Phase 2 Study to Assess Activity and Safety of Front-line Ibrutinib Plus Rituximab (IR) in Unfit Patients With Chronic Lymphocytic Leukemia

Read time: 1 mins
Last updated:2nd Sep 2014

The present study aims at evaluating whether treatment with two different drugs, Ibrutinib and Rituximab is both efficient and safe for newly diagnosed patients with chronic lymphocytic leukemia.

Category Value
Study start date 2014-09-02

View full details